Myocardial infarction in type 2 diabetes using sodium–glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning

Tomohide Yamada, Kosuke Iwasaki, Shotaro Maedera, Katsuya Ito, Tomomi Takeshima, Hisashi Noma, Nobuhiro Shojima

Current Medical Research and Opinion · 2019 · 24 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Machine learning analysis suggested the risk of MI was 37% lower for type 2 diabetes patients without prior MI using GLP-1RAs versus DPP-4is, while the risk was 19% lower for SGLT-2is versus DPP-4is.

References

13